Bluejay Diagnostics, Inc. financial data

Symbol
BJDX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
360 Massachusetts Avenue, Suite 203, Acton, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 348 % -20.9%
Debt-to-equity 32.1 % +17.4%
Return On Equity -156 % -25.2%
Return On Assets -118 % -20.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.9M shares +2070%
Common Stock, Shares, Outstanding 17.8M shares +1339%
Entity Public Float 3.03M USD -85.8%
Common Stock, Value, Issued 1.78K USD +1338%
Weighted Average Number of Shares Outstanding, Basic 9.56M shares +6831%
Weighted Average Number of Shares Outstanding, Diluted 9.56M shares +6831%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 249K USD
Research and Development Expense 4.21M USD -26.9%
Selling and Marketing Expense 305 USD -99.8%
General and Administrative Expense 3.86M USD -7.6%
Operating Income (Loss) -8.07M USD +22.2%
Nonoperating Income (Expense) -120K USD -378%
Net Income (Loss) Attributable to Parent -8.59M USD +14.4%
Earnings Per Share, Basic 25.8 USD/shares +99%
Earnings Per Share, Diluted 25.8 USD/shares +99%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.76M USD +13.4%
Inventory, Net 671K USD
Assets, Current 6.57M USD +0.61%
Property, Plant and Equipment, Net 1.53M USD +16.1%
Operating Lease, Right-of-Use Asset 227K USD -38.1%
Other Assets, Noncurrent 23.6K USD -21.1%
Assets 8.35M USD +1.3%
Accounts Payable, Current 317K USD -58.1%
Employee-related Liabilities, Current 534K USD +238%
Accrued Liabilities, Current 1.11M USD +28.3%
Liabilities, Current 1.05M USD -62.5%
Operating Lease, Liability, Noncurrent 130K USD -40.8%
Other Liabilities, Noncurrent 9.53K USD -27.9%
Liabilities 1.19M USD -60.8%
Retained Earnings (Accumulated Deficit) -33.2M USD -34.8%
Stockholders' Equity Attributable to Parent 7.16M USD +37.4%
Liabilities and Equity 8.35M USD +1.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.3M USD +21.7%
Net Cash Provided by (Used in) Financing Activities 2.78M USD
Net Cash Provided by (Used in) Investing Activities -35.4K USD +89.6%
Common Stock, Shares Authorized 250M shares +3233%
Common Stock, Shares, Issued 17.8M shares +1339%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.92M USD -190%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.76M USD +13.4%
Deferred Tax Assets, Valuation Allowance 7.69M USD +66.2%
Deferred Tax Assets, Gross 7.69M USD +66.2%
Operating Lease, Liability 242K USD +1241%
Depreciation 19.7K USD -83.6%
Payments to Acquire Property, Plant, and Equipment 35.4K USD -89.6%
Lessee, Operating Lease, Liability, to be Paid 261K USD +1155%
Property, Plant and Equipment, Gross 2.83M USD +11.4%
Operating Lease, Liability, Current 111K USD -33.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 100K USD +1980%
Lessee, Operating Lease, Liability, to be Paid, Year One 100K USD +1980%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19.8K USD +606%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25K USD +420%
Deferred Tax Assets, Operating Loss Carryforwards 4.55M USD +49.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 25K USD -75%
Operating Lease, Payments 44.2K USD +1.49%
Additional Paid in Capital 28.7M USD +1.48%
Share-based Payment Arrangement, Expense 7.11K USD -97.6%
Interest Expense 186K USD